Verve Therapeutics, Inc. (VERV): Price and Financial Metrics
VERV Price/Volume Stats
| Current price | $11.13 | 52-week high | $11.40 |
| Prev. close | $11.10 | 52-week low | $2.86 |
| Day low | $11.10 | Volume | 10,306,600 |
| Day high | $11.25 | Avg. volume | 3,597,874 |
| 50-day MA | $8.21 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | 992.16M |
VERV Stock Price Chart Interactive Chart >
Verve Therapeutics, Inc. (VERV) Company Bio
Verve Therapeutics, Inc. is a genetic medicines company engaged in the development of a new approach to the care of cardiovascular disease. It aims to transform treatment from chronic management to single-course gene editing medicines. Its goal is to disrupt the chronic care model for CVD by providing a new therapeutic approach with single-course in vivo gene editing treatments focused on addressing the root causes of this highly prevalent and life-threatening disease.
VERV Price Returns
| 1-mo | -1.33% |
| 3-mo | 114.45% |
| 6-mo | 46.25% |
| 1-year | 59.00% |
| 3-year | -50.75% |
| 5-year | N/A |
| YTD | 97.34% |
| 2024 | -59.54% |
| 2023 | -27.96% |
| 2022 | -47.52% |
| 2021 | N/A |
| 2020 | N/A |
Loading social stream, please wait...